7 As a result, carriers are thoughtfully evaluating the efficacy and use cases of these new drugs to determine how they should be covered, based on the latest clinical studies and medical evidence
RECENT GUIDANCE ON THE USE OF GLP-1 RAs IN PATIENTS WITH T2D In consideration of recently reported cardiovascular and renal outcome data, multiple organizations have published updated guidance over the last several years regarding the use of glucose-lowering agents in patients with T2D to mitigate cardiovascular and renal risks
While supplements and trendy products often steal the spotlight, the most powerful tools are often already in your kitchen
For weight loss peptides like semaglutide and tirzepatide, the dosing is very different
Hence, it appears that the antidepressant effects resulting from GLP-1 receptor activation by semaglutide may be deeply intertwined with its ability to mitigate neurodegeneration and inflammation
Alcohol consumption can also play a role